Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry-Reference-Cited by-同舟云学术

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry

Published:2017-01 Issue:1 Volume:5 Page:1381544
ISSN:2001-6689
Container-title:Journal of Market Access & Health Policy
language:en
Short-container-title:Journal of Market Access & Health Policy

Author:

Badora Karolina¹,Caban Aleksandra¹,Rémuzat Cécile²,Dussart Claude³⁴,Toumi Mondher⁵

Affiliation:

1. Creativ-Ceutical Poland, Cracow, Poland

2. Creativ-Ceutical France, Paris, France

3. Laboratoire Parcours Santé Systémique, Université Claude Bernard, Lyon, France

4. Faculté de Médecine Laennec, Université de Lyon, Lyon, France

5. Faculté de Médecine, Laboratoire de Santé, Université de la Méditerranée, Marseille, France

Publisher

Informa UK Limited

Link

https://tandfonline.com/doi/pdf/10.1080/20016689.2017.1381544

Reference3 articles.

1. Implementation of the 2011 Reimbursement Act in Poland: Desired and undesired effects of the changes in reimbursement policy

2. Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers and facilitators to guideline for the management of pediatric off-label use of drugs in China: a qualitative descriptive study;BMC Health Services Research;2024-04-05

2. Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015–2018 Years;Frontiers in Pharmacology;2020-08-14

3. An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries;Frontiers in Public Health;2018-03-05